Open-Label Extension Study of Marstacimab: Pfizer Has Reported a Fatal Event
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
“Safety Signal: Perioperative management with anti-TFPI therapy!
Pfizer has reported a fatal event in the open-label extension study of marstacimab (B7841007). The participant (haemophilia A with inhibitors) passed away on Dec 14 following a cerebellar infarction and cerebral haemorrhage.
What was the clinical context?
The event occurred perioperatively during minor surgery. The patient was receiving marstacimab prophylaxis + recombinant Factor VIIa (rFVIIa).
The Challenge
As we advance rebalancing therapies (anti-TFPI), this underscores the critical physiological threshold of thrombin generation. The synergy between TFPI inhibition and bypassing agents—particularly in surgical contexts—remains a complex therapeutic balance.
Status
While marstacimab is approved in the EU for non-inhibitor patients with haemophilia A and B, this event in the inhibitor cohort has triggered an immediate review of surgical management protocols by regulators and the DMC.
Full adjudication to better understand the safety margins and risk mitigation is needed for these novel agents.”
Title: WFH and NBDF statement on severe adverse event with marstacimab rebalancing agent for hemophilia
Read the full paper here.
Stay updated on all scientific advances from Wolfgang Miesbach with Hemostasis Today.
-
Jul 17, 2026, 23:05Leonardo Roever: New Perspectives on Thromboinflammation in Acute Ischemic Stroke
-
Jul 17, 2026, 22:36Maeva May: Start Your Stroke Research Career with a Stroke Association Fellowship
-
Jul 17, 2026, 20:19Thomas Muenzel: Proud to Deliver the Sylviane Lévy-Toledano Memorial Plenary Keynote Lecture at ISTH 2026
-
Jul 17, 2026, 20:16Karin Leiderman: Proud of Jamie Madrigal for Receiving the JTH Editors’ Award
-
Jul 17, 2026, 20:14Lily Bull: Presenting New Research and Building Connections at ISTH 2026
-
Jul 17, 2026, 20:12Modern Concepts in Traumatic Disseminated Intravascular Coagulation – JTH
-
Jul 17, 2026, 20:10Nahid A. Qushmaq: Science, Collaboration, and Inspiration at ISTH 2026
-
Jul 17, 2026, 18:20Sarah Jones: Bringing Vessel-on-a-Chip Research to ISTH 2026
-
Jul 17, 2026, 18:06Virginia Barras Sánchez: United by a Commitment to Hemophilia at ISTH 2026